© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Estrone holds a solid place in the history of endocrinology. Back in the 1920s, researchers made huge leaps while hunting for hormones managing sexual development. Adolf Butenandt, a German chemist and Nobel laureate, had a hand in isolating estrone from the urine of pregnant women, confirming earlier suspicions about potent natural estrogens. Chemists went to great lengths processing thousands of liters of biological fluids to recover just grams of pure estrone, showing just how rare and valuable this compound once proved. Not long after, scientists sorted out how to extract and, eventually, synthesize it. Those early discoveries shifted how medicine approached conditions tied to hormonal deficits or imbalances, especially for women entering menopause or managing ovarian disorders. Major pharmaceutical companies jumped into the game, and, for decades, estrone established itself as a reliable choice for hormone therapies.
Estrone stands out as a natural estrogenic steroid, usually found in both plants and mammals. Commercially, manufacturers present it as a crystallized powder, often with pharmaceutical-grade purity for use in research as well as medication. In the clinic, estrone sees action for hormone therapy, especially in postmenopausal women dealing with symptoms like hot flashes or osteoporosis. Unlike more aggressive forms of estrogen therapy, estrone often acts as a gentler supplement, thanks to its unique conversion pathways in the body. Its use stretches into laboratory research, where scientists look at its role in metabolism, cellular signaling, and cancer biology.
Estrone's chemical formula is C18H22O2, tipping the scales at about 270.36 g/mol. This compound shows up as a white to off-white crystalline powder, practically insoluble in water but dissolves in organic solvents like ethanol, DMSO, and acetone. Its melting point sits close to 254°C, showcasing its stability under typical lab conditions. The structure features a phenolic A-ring, which is common among estrogens, giving it estrogenic activity through binding to estrogen receptors. The molecule stays relatively stable in most storage settings as long as moisture and light stay away, which extends shelf life and minimizes breakdown into unwanted side products.
Certified estrone products show purity levels above 98% by HPLC or GC analysis. Manufacturers clearly state batch numbers, expiration dates, source information, and proper storage guidelines directly on labels. The recommended storage temperature remains at 2-8°C, avoiding direct sunlight and moisture. Vials or bottles usually carry hazard pictograms, signal words, and standardized warnings dictated by global safety regulations like GHS. In some regions, pharmaceutical-grade estrone gets tracked tightly, with records maintained to avoid misuse. Reagent-grade materials, used mostly in industrial or research settings, must list manufacturing techniques, impurity profiles, and certifications regarding heavy metals or solvent residues.
At the industrial scale, estrone production started with extraction from urine—laborious but effective for small batches. With advancing chemical knowledge, synthetic approaches took over. Chemists usually begin with plant sterols or cholesterol as feedstock, which offer cheap, abundant sources. These undergo a series of oxidation, reduction, and hydrolysis reactions, eventually converting into the characteristic aromatic A-ring and 17-keto structure. Techniques like catalytic hydrogenation and selective dehydrogenation play big roles, as does careful control over reaction temperatures and solvents. Chromatographic purification steps follow, peeling away trace by-products so that only estrone’s pure crystalline form survives.
Estrone participates in a host of reactions sued frequently in research. Reduction at the 17-keto group produces estradiol, a stronger estrogen, vital for clinical therapies. Conversion to estriol happens through biochemical hydroxylation pathways and is studied intensively in pregnancy and cancer research. Chemists also use estrone as a starting scaffold for synthesizing labeled radioactive tracers, preparing derivatives for tracking estrogen activity in body tissues or diagnostic imaging. In academic labs, functional group modifications help probe receptor interactions, metabolism, and detoxification processes. The phenolic nature of the A-ring lets estrone react in controlled polymerizations or chemical tagging for biochemical assays.
Worldwide, estrone picks up a variety of names in trade and pharmaceutical circles. Common synonyms include Oestrone (British English), Estra-1,3,5(10)-trien-17-one, and Folliculin. In clinical markets, estrone sometimes appears under brand names like Estrovarin or Oestroform. Chemical suppliers might list CAS Registry Number 53-16-7, which provides an international shorthand for tracking and procurement.
Working with estrone calls for strict handling procedures, even in low volumes. Like other hormone-active molecules, it poses health risks through dermal absorption, inhalation, or accidental ingestion. Laboratory safety protocols keep the compound away from open skin and mucous membranes; gloves, goggles, and lab coats aren’t optional. Fume hoods protect workers during weighing and solution preparation. Spills must be swept up with absorbent pads, and contaminated materials head into hazardous waste bins. Long-term exposure studies underline the dangers of hormonal disruption—think reproductive problems or increased cancer risk—so employers train staff regularly on updated safety practices. Pharmaceutical-grade production follows GMP guidelines, with sealed systems and periodic environmental monitoring to prevent cross-contamination.
Estrone serves in medicine as a pillar of hormone replacement, especially for postmenopausal complications. Some cancer patients receive estrone as part of their treatment plan, given its balance between potency and side-effect profile. Researchers use estrone as a reference standard when measuring estrogen levels in biological fluids or evaluating new diagnostic tests. The compound crops up in cell culture studies examining hormone receptor signaling, inflammation, and cell proliferation. In some veterinary applications, estrone treatment helps manage reproductive disorders in valuable breeding animals.
Scientists continue to explore how estrone fits into the broader web of estrogen metabolism. Decades of laboratory work have turned up nuanced differences between estrone, estradiol, and estriol, especially in tissue responses and risk profiles for estrogen-driven diseases. Cutting-edge research now asks whether specific estrone metabolites could play early warning roles in cancer detection. Genomic and proteomic tools allow deeper dives into how estrone changes gene expression in target tissues. Pharmaceutical developers keep tinkering with modified estrone structures, searching for compounds that coax unique therapeutic responses or carry a reduced side-effect burden.
Toxicological inquiries into estrone cover both acute and chronic exposure. High doses trigger reproductive disturbances, abnormal tissue proliferation, and sometimes tumor growth in rodent studies. Subtle, low-level exposures over many years still spark concern, especially for occupational handlers and people living near pharmaceutical plants or livestock operations where estrogens persist in wastewater. Researchers look hard at links between estrone and breast or endometrial cancer, as well as liver function disturbances. Every new study pushes regulators toward revisiting safe workplace limits, environmental monitoring, and remediation options in wastewater treatment.
Looking ahead, the future of estrone research and application points in several promising directions. Advances in biotechnology mean extraction and synthesis could grow greener, cutting down waste and hazardous by-products. Novel drug delivery systems might offer more targeted estrone therapies with fewer risks for off-target hormone-sensitive tissues. With precision medicine on the rise, scientists could tailor hormone therapies based on a patient’s genetics or metabolic quirks, reducing unwanted side effects. Environmental research teams keep hunting for better filtration techniques that clean up estrogenic compounds from industrial and agricultural run-off. As analytical technology improves, public health officials and clinicians gain tougher tools for tracking and managing both the benefits and dangers of this historic, powerful molecule.
Estrone is a naturally occurring estrogen hormone, found most abundantly in women after menopause. Doctors may prescribe estrone when the body’s estrogen levels dip and symptoms begin to surface. I watched my own mother deal with hot flashes and night sweats after her menopause, struggling with the discomfort day in and day out. For her and many others, hormone replacement therapy can feel like a lifeline.
Estrone has helped women tackle symptoms brought on by reduced estrogen. These can include vaginal dryness, difficulty sleeping, and bone thinning. Women share with me that dryness and discomfort make intimacy and daily routines more difficult than many realize. Without enough estrogen, bones lose density faster, leading to osteoporosis. The U.S. National Osteoporosis Foundation highlighted that half of women over 50 will break a bone due to osteoporosis. Estrone can slow that process and make life feel more manageable.
The FDA approves certain forms of estrone for hot flashes, burning or irritation in the vagina, and atrophic vaginitis. I’ve seen patients regain a degree of confidence and comfort when symptoms fade. Because estrone replaces what the body lost, it can fill the gap when natural hormone production tails off. Doctors rely on bloodwork and clinical symptoms before recommending treatment, as not all forms of hormone therapy suit every person.
Concerns have always followed the use of any estrogen, including estrone. Years ago, the Women’s Health Initiative trial uncovered increased risks for blood clots, breast cancer, and stroke in some women taking hormone therapy. I remember the confusion and anxiety that swept through clinics as women tried to decide if relief was worth the risk. Not everyone needs estrone, and its use should factor in the personal and family health histories, age, and time since menopause.
Some women face higher risks than others. The Mayo Clinic and American College of Obstetricians and Gynecologists both suggest the lowest effective dose for the shortest possible duration. I tell family and friends who ask about estrone to have honest talks with their care providers, weighing both the short-term relief and long-term risks.
Treating menopause today feels less one-size-fits-all than before. Other medications like SSRIs or new non-hormonal drugs may help with hot flashes for some women. Lifestyle changes, including regular exercise and nutrition, play a role as well. Decisions about estrone work best with a plan that involves weighing symptoms, medical history, and patient goals.
Estrone isn’t the first or only choice for every woman. Clinicians continue to explore new approaches while monitoring safety data. Regular check-ups, honest dialogue, and shared decision-making improve the odds of a positive outcome.
I’ve seen firsthand how restored comfort and reduced symptoms can lead to better sleep, more social activity, and improved mood in women using estrone. No pill or patch solves everything. Support, good information, and staying alert to changes allow women and their providers to adjust therapy as life goes on.
Estrone belongs to the estrogen family and usually comes up in hormone therapy for menopause or certain cancers. Doctors sometimes prescribe it to help with symptoms that show up when the body’s own estrogen drops—think hot flashes, night sweats, bone thinning. Estrone’s job seems simple, but like many hormones, its effects can spread wide through the body.
Some side effects show up fairly quickly. Breast tenderness often tops the list. Many women describe this as a dull ache or swelling, similar to what can happen before a period. Headaches and nausea crop up, too, and those can stick around for a while.
Fluid retention can sneak up, leading to swelling in the ankles or hands. I’ve seen patients worry their rings won’t fit or their shoes feel tight. A few will notice their appetite changes or find it easier to gain weight, which gets frustrating when trying to manage overall health during menopause.
Estrone, like other estrogens, nudges the risk of certain conditions higher over the long haul. Blood clots remain a real concern. Estrogens can thicken blood a little, spiking the risk of clots forming in the legs, lungs, or brain. Stroke can result if clots block a vessel to the brain.
Women who take estrone sometimes see blood pressure climb. For those with a history of high readings, doctors usually keep a close eye. Evidence also suggests estrone nudges up the risk of certain cancers — particularly breast and uterine cancers. The body’s tissues might react to the higher estrogen and start to grow in harmful ways, so oncologists weigh that risk before starting anyone on treatment. Regular mammograms and doctor visits matter more for those on estrogen therapy.
Estrogen can play tricks on mood and sleep. Some people notice mood swings or a feeling of anxiety that wasn’t there before. On the flip side, for certain folks, estrone relieves depression that flares up with hormone loss. Sleep changes may come in the form of restlessness or vivid dreams.
Memory sometimes drags, with a foggy feeling that makes daily tasks harder. Doctors aren’t completely sure why this happens, but it probably ties back to estrogen’s many roles in the brain.
Doctors rarely leave people without backup. Lowering the dose helps some patients with short-term complaints like headaches or breast tenderness. Others find relief by switching to a different form of estrogen that the body tolerates better. For those concerned about clots, regular movement and staying hydrated play a big role in lowering the risk.
It helps to take note of every new symptom. Even a small change can matter. Pharmacists often remind people to check in if they see anything new—a new ache, a swelling, a sudden sadness. Quick communication lets care teams tweak treatment or run tests.
Lifestyle makes a difference, too. A diet high in fiber and low in processed food can help support metabolism and hormone balance. Weight-bearing exercise isn’t just for the bones—regular movement keeps blood flowing and helps stabilize mood. These changes add up, especially when dealing with hormone shifts and possible medication side effects.
No one should have to navigate side effects alone. Honest conversations help prevent lasting problems. Bring up every concern—big or small—to the doctor or pharmacist. Staying informed supports better health and brings more control to a process that can feel overwhelming.
Deciding to take estrone often comes after a lot of conversations with healthcare providers. Estrone, an estrogen hormone, can play a role for women dealing with symptoms from menopause, issues with estrogen deficiency, or even certain cancers. Before thinking about the “how,” many people first need a clear diagnosis and a plan from someone who knows their health inside out. Your doctor gets a full picture of your symptoms, health history, and any risks related to hormone therapy.
Estrone comes in tablets, injections, and sometimes creams. People ask about which form works best, but what actually matters is that different forms suit different situations. Tablets show up in daily routines for many. Injections, on the other hand, get spaced out by a week or two. For skin applications, some people appreciate creams because they don’t affect the whole body as much. Dose matters just as much as form. Too little doesn’t help, but too much can cause more harm than good, bringing on headaches, nausea, or bigger risks like blood clots.
The most important thing I’ve learned talking with women in menopause clinics is how easy it is to forget a dose or stop the medicine when symptoms quiet down. Yet, missing doses messes with hormone levels. I’ve seen people deal with surprise hot flashes or mood swings after not taking estrone as directed. This stuff works best when taken at the same time daily and paired with regular check-ins with your doctor. Adjustment happens after lab work and good conversation, not by guessing at home.
People can overlook how serious estrogen therapy can get if it’s not managed right. Heart attacks, strokes, breast cancer, or blood clots show up on every medication leaflet for a reason. Smoking, being over 60, or having a family history of cancers can increase these risks. Every person needs to track their health closely with their provider. An honest conversation about past illnesses, family history, and personal values should always guide decisions about estrone and any hormone therapy. The FDA requires a medication guide for a reason.
No medicine works in a vacuum. I’ve noticed people who do best with estrone tend to put in effort elsewhere, too. They eat lots of fruits and vegetables, keep physically active, and weigh themselves regularly. They don’t smoke and limit alcohol. These steps help keep blood vessels and bones strong. Regular check-ups, mammograms, and blood work stay just as important as taking the dose itself. Taking estrone safely works best as part of a bigger approach to health, not a quick fix.
Only your doctor knows the right answer for how and if you should take estrone. Google can’t see your chart. You know your body better than anybody, so speak up about concerns or symptoms—even small changes. Keep a list of your medicines and allergies, and ask questions at each visit. Some people get by with a short course, while others stay on it longer, and each situation deserves respect and careful planning. Trust between you and your doctor will take you further than any pill.
Estrone is a type of estrogen hormone made naturally in the human body. It often shows up in hormone replacement therapies and some fertility treatments. As a writer with a science background and a parent who has faced decisions about medication during pregnancy, I've learned how important it is to understand what goes inside your body, especially if you're expecting or nursing.
Doctors don’t give Estrone to pregnant women unless they have a really important reason. It’s not just a matter of caution; there are real concerns about what synthetic estrogens can do to a developing baby. The FDA lists estrogens, including estrone, as category X for pregnancy—meaning the risks to the fetus far outweigh any benefits.
Estrone can cross the placenta. Animal studies have shown that high estrogen levels before birth can cause malformations of reproductive organs or other birth problems. No parent wants to hear about risks like that. In the 1950s and 60s, another synthetic estrogen (DES) led to tragic health problems in daughters of women who took it while pregnant. Those daughters faced a higher risk of certain cancers and fertility problems. That history rattles any trust in using strong hormones during pregnancy.
For breastfeeding moms, the concerns aren’t quite as clear, but the alarm bells still ring. Estrone doesn’t just stay in your system—I’ve read studies showing it passes into breast milk. Babies’ bodies handle hormones very differently from adults, and their developing systems are sensitive to anything out of the ordinary. High estrogen levels at such a young age can affect infants’ developing endocrine and reproductive organs.
Many traditional hormone treatments, including those containing estrone, carry warnings against their use during breastfeeding for this reason. The American Academy of Pediatrics recommends against most estrogen medications for lactating mothers because of their possible effects on the nursing infant and milk supply.
Obstetricians and pediatricians almost always recommend avoiding strong hormonal medications unless there’s a life-saving concern. If a pregnant or breastfeeding parent needs estrogen replacement because their own body doesn’t make enough, the decision gets complicated. Doctors weigh the expected benefits of treatment against all potential risks for mother and baby. That means real-world advice comes from conversations, not internet search results.
Parents want practical solutions. If you rely on hormone therapy and become pregnant, or plan to breastfeed, talk with your healthcare provider right away. Sometimes other medications or even changing doses can help reduce risks. I’ve seen cases where doctors switch to safer alternatives or recommend non-hormonal treatments to protect both parent and child.
One safe practice stands out—open and direct communication with your care team. Keep all your medications organized. Don’t stop or start anything without talking it over with a professional. Pay attention to any new symptoms or side effects, and speak up early.
Health is personal. Decisions about estrone, or any strong medication, need careful thought. Science strongly supports keeping estrone out of pregnancy and breastfeeding unless absolutely essential. That’s the safest path for both parent and child, backed by years of research and real-life lessons from families everywhere.
Estrone acts as one of the key forms of estrogen inside the body. After years studying pharmacy and working with patients, I’ve seen how easily hormones like estrone get tangled up with other medications. Many people use estrone for hormone replacement therapy, especially during menopause. What often gets overlooked: medicines and supplements can spark all sorts of unexpected changes when mixed with estrone.
Blood thinners like warfarin often react with hormone supplements. Taking estrone may boost the effect of warfarin, raising the risk for bruising or even dangerous bleeding. Doctors have spotted changes in INR (a blood-clotting test) shortly after starting estrogen treatment. It’s not rare for someone to end up needing a new dose of their blood thinner after adding hormone therapy.
Steroid drugs such as prednisone can throw hormone levels out of balance. Sometimes estrone makes these steroids less effective, but other times it increases side effects. After counseling patients for years, I often tell folks to pay attention to symptoms like swelling, unexplained tiredness, and changes in mood. These can signal things shifting inside the body, faster than blood tests reveal.
Antibiotics, especially rifampin, can ramp up the breakdown of estrone in the liver. Birth control pills and hormone patches run into the same trouble. I’ve spoken with quite a few women who felt off after starting antibiotics, only to learn later that their hormone therapy stopped working. Rifampin isn’t the only culprit—certain anti-seizure drugs can lower estrone levels too.
St. John’s Wort, sold in plenty of health stores as a mood booster, speeds up the body’s breakdown of estrogens. Folks using estrone and herbs like this, especially without talking to their pharmacy or doctor, can end up with hot flashes or swings in mood. The higher turnover in the liver leaves them almost “underdosed” on their hormone support.
Not every person will react the same way to a mix of medications. Factors like age, genetics, liver function, and what someone eats every day all add up. I’ve worked with two women on nearly identical regimens: one breezed through with no trouble, the other faced weeks of discomfort from headaches and unexpected bleeding. No medication list can ever replace real conversations and steady follow-up.
Staying safe with estrone means building trust with a healthcare provider—not just at the start, but in the months that follow. A good habit means laying out every pill, supplement, and vitamin during appointments. Don’t skip the herbs, the fish oil, or the tea—these can matter just as much as the orange prescription bottle.
Pharmacists, in my experience, spot these risks before trouble starts. Plenty of stories stick with me: a new supplement almost sending a regular into a spiral, or an antibiotic rewrite causing hot flashes out of nowhere. Walking into the local pharmacy instead of ordering everything online keeps safety nets in place.
Reading package inserts leaves gaps. Relying on lived experience, open communication, and regular check-ins goes much further. Getting this right improves quality of life and makes hormone therapy less a guessing game and more a well-guided journey.
| Names | |
| Preferred IUPAC name | estra-1,3,5(10)-trien-3-ol-17-one |
| Pronunciation | /ˈɛstrəʊn/ |
| Identifiers | |
| CAS Number | 53-16-7 |
| Beilstein Reference | Beilstein 2053322 |
| ChEBI | CHEBI:17263 |
| ChEMBL | CHEMBL826 |
| ChemSpider | 5318 |
| DrugBank | DB00655 |
| ECHA InfoCard | 100.000.028 |
| EC Number | 3.1.1.152 |
| Gmelin Reference | Gmelin Reference: 140134 |
| KEGG | C00468 |
| MeSH | D004967 |
| PubChem CID | 5870 |
| RTECS number | KW2975000 |
| UNII | YL5FZ2Y5U1 |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | DTXSID4020731 |
| Properties | |
| Chemical formula | C18H22O2 |
| Molar mass | 270.366 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 1.2 g/cm³ |
| Solubility in water | Slightly soluble |
| log P | 3.13 |
| Vapor pressure | 1.15E-08 mmHg at 25°C |
| Acidity (pKa) | 10.4 |
| Basicity (pKb) | 7.82 |
| Magnetic susceptibility (χ) | -76.0·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.594 |
| Dipole moment | 1.7972 Debye |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 361.5 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -275.5 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -3624 kJ/mol |
| Pharmacology | |
| ATC code | G03CA02 |
| Hazards | |
| Main hazards | Suspected of causing cancer. |
| GHS labelling | GHS02, GHS07, GHS08 |
| Pictograms | **"GHS06, GHS08"** |
| Signal word | Danger |
| Hazard statements | H302, H315, H319, H335, H351, H360 |
| Precautionary statements | P201, P202, P280, P308+P313, P405, P501 |
| NFPA 704 (fire diamond) | 2-2-0 |
| Flash point | flash point: 185°C |
| Autoignition temperature | 360 °C |
| Lethal dose or concentration | LD50 intravenous mouse 24 mg/kg |
| LD50 (median dose) | 250 mg/kg (rat, oral) |
| NIOSH | KWQ8NBI007 |
| PEL (Permissible) | PEL: 5 mg/m³ |
| REL (Recommended) | 0.001 mg/kg bw |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Estradiol Estriol Estetrol Equilin Equilenin Progesterone Testosterone Androstenedione |
